Farmed shrimp accounts for over 55% of global shrimp production with the industry valued at US$8-9 Billion. Most production occurs within coastal marine ponds, which can be subject to disease outbreaks. Many disease outbreaks are associated with bacterial diseases, specifically Vibrio spp.. Acute Hepatopancreatic Necrosis Disease (AHPND), Penaeus monodon Mortality Syndrome (PmMS) and Translucent Post-larval disease (TPD) are examples of toxic expressing Vibrio infections that have caused rapid onset mortality exceeding 90%. The circumstances leading to Vibrio-related disease outbreaks are not fully understood but appear to be mediated in part by environmental factors. Current treatments include antibiotics; however, antibiotic resistance and environmental release are major concerns.
Currently t here is growing recognition of the effect of the core microbiome within culture environments on system health. Bacteria are responsible for metabolic functions including nutrient cycling, but maintaining a stable microbiome is challenging as system conditions can shift rapidly. A novel approach to microbiome modulation is the inclusion of a holobiont, a biological unit consisting of a multicellular host and its associated community of microorganisms which function as as an ecological unit. Recent research has demonstrated beneficial impact of the inclusion of the seaweed Ulva as a holobiont organism integrated aquaculture systems. Ulva can modulate the abundance and activity of core bacterial species, including those involved in nitrogen cycling, and reduce harmful species such as Vibrio.
This study investigated Ulva ohnoi integration as a potential mechanism to manage Vibrio spp. and improve Penaeus monodon health in land-based systems. The effectiveness of Ulva ohnoi to reduce Vibrio was evaluated in both lab-based clearance assays and in experimental IMTA systems . Lab trials investigated the effect of Ulva modulated control of V. harveyi (identified as the cause of PmMS within Australia ) over an 8-day period , with Ulva treatments demonstrating a significant (p < 0.001) reduction in Vibrio after 5 days compared to controls absent of Ulva (Figure 1). Experimental IMTA trials further confirmed Ulva’ s ability to improve system health over a one-month period, with significant reduction in Vibrio sp. and enhanced prawn survival rates.